Dental care company MakeO has secured Rs 90 crore in a funding round led by Singularity AMC to scale its operations across India and Southeast Asia. The company, which operates the Toothsi brand, is currently EBITDA-level profitable with annual revenue exceeding Rs 500 crore, and plans to use the capital to strengthen its clinic network and manufacturing capabilities.
MakeO has secured Rs 90 crore in fresh capital led by Singularity AMC. The investment round also saw participation from the DSP Family Office, Genesis, and Unispace Ventures. The company, which operates as the parent entity for the dental care brand Toothsi, plans to use these funds to expand its clinic footprint across India and Southeast Asia, while simultaneously upgrading its manufacturing facilities in the Mumbai Metropolitan Region.
The company has reached a notable financial milestone by achieving EBITDA-level profitability with annual revenue exceeding Rs 500 crore. This financial position is important for a growth-stage firm, as it transitions from a cash-burning model to scaling established operations. The business currently manages a network of over 60 clinical centers and collaborates with approximately 1,100 partner dentists across 10 countries.
MakeO is pursuing a dual-track strategy to drive its next phase of growth. This involves both organic expansion and the tactical acquisition of regional clinic chains and other clear aligner businesses. The company has already executed this strategy through the acquisition of Singapore-based Zenyum and India-based Apple Dental. These moves are designed to build a more integrated dental platform, allowing the company to evolve from a niche aligner provider into a comprehensive dental care service provider.
While the company is scaling rapidly, there are operational factors to consider. The successful integration of large international acquisitions involves significant execution risk, as managing businesses across diverse markets can be complex. Furthermore, the firm must balance the high operational costs associated with running a physical clinic network and maintaining specialized manufacturing infrastructure.
Additionally, because the company’s services are often linked to consumer discretionary spending, its performance will remain sensitive to the overall economic environment and competitive dynamics in the dental-tech sector. The ability to maintain profit margins while increasing capital spending on new clinics and technology will be a key monitorable. Observers will likely track how efficiently the firm integrates its recent international acquisitions and the speed at which it penetrates tier-two and tier-three Indian cities.